ANGLE (AGL) Competitors GBX 8 -0.50 (-5.88%) As of 12:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesBuy This Stock AGL vs. SSY, FME, BNR, CON, AMED, SHC, TALK, AMS, DXRX, and YGENShould you be buying ANGLE stock or one of its competitors? The main competitors of ANGLE include Scisys Group (SSY), Future Metals (FME), Burning Rock Biotech (BNR), Connemara Mining (CON), Amedeo Resources (AMED), Shaftesbury Capital (SHC), TalkTalk Telecom Group (TALK), Advanced Medical Solutions Group (AMS), Diaceutics (DXRX), and Yourgene Health (YGEN). ANGLE vs. Scisys Group Future Metals Burning Rock Biotech Connemara Mining Amedeo Resources Shaftesbury Capital TalkTalk Telecom Group Advanced Medical Solutions Group Diaceutics Yourgene Health Scisys Group (LON:SSY) and ANGLE (LON:AGL) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, community ranking, institutional ownership, analyst recommendations and media sentiment. Does the media favor SSY or AGL? In the previous week, Scisys Group's average media sentiment score of 0.00 equaled ANGLE'saverage media sentiment score. Company Overall Sentiment Scisys Group Neutral ANGLE Neutral Do analysts rate SSY or AGL? ANGLE has a consensus target price of GBX 40, suggesting a potential upside of 400.00%. Given ANGLE's stronger consensus rating and higher possible upside, analysts clearly believe ANGLE is more favorable than Scisys Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scisys Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00ANGLE 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in SSY or AGL? 18.8% of ANGLE shares are owned by institutional investors. 16.2% of ANGLE shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable earnings & valuation, SSY or AGL? Scisys Group has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Scisys Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScisys Group£59.06M0.00N/A£1.40N/AANGLE£2.44M10.55-£21.76M-£6.76-1.18 Does the MarketBeat Community believe in SSY or AGL? ANGLE received 78 more outperform votes than Scisys Group when rated by MarketBeat users. Likewise, 62.46% of users gave ANGLE an outperform vote while only 42.34% of users gave Scisys Group an outperform vote. CompanyUnderperformOutperformScisys GroupOutperform Votes10542.34% Underperform Votes14357.66% ANGLEOutperform Votes18362.46% Underperform Votes11037.54% Is SSY or AGL more profitable? Scisys Group has a net margin of 0.00% compared to ANGLE's net margin of -890.91%. Scisys Group's return on equity of 0.00% beat ANGLE's return on equity.Company Net Margins Return on Equity Return on Assets Scisys GroupN/A N/A N/A ANGLE -890.91%-76.01%-29.89% SummaryANGLE beats Scisys Group on 7 of the 13 factors compared between the two stocks. Remove Ads Get ANGLE News Delivered to You Automatically Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGL vs. The Competition Export to ExcelMetricANGLEDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£25.78M£713.26M£5.29B£2.47BDividend Yield1.12%5.44%5.11%4.95%P/E Ratio-1.181.7221.65130.51Price / Sales10.55292.01371.09230,385.31Price / Cash5.8011.4238.1527.95Price / Book0.872.756.374.42Net Income-£21.76M£308.37B£3.20B£5.79B7 Day PerformanceN/A2.76%1.79%5.37%1 Month Performance-13.26%-13.25%-9.41%3.79%1 Year Performance-36.00%-11.52%9.61%104.20% ANGLE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGLANGLE1.5681 of 5 starsGBX 8-5.9%GBX 40+400.0%-33.3%£25.78M£2.44M-1.18650SSYScisys GroupN/AN/AN/AN/A£75.14M£59.06M180.711,376FMEFuture MetalsN/AGBX 0.53-3.6%N/A-66.9%£6.06M£155,836.16-1.54123,200Gap UpBNRBurning Rock BiotechN/AN/AN/AN/A£3.77MN/A0.001,390Gap DownHigh Trading VolumeCONConnemara MiningN/AN/AN/AN/A£1.52MN/A-3.83N/AAMEDAmedeo ResourcesN/AN/AN/AN/A£0.00N/A0.0020,000SHCShaftesbury Capital2.3799 of 5 starsGBX 126.45+2.6%GBX 174+37.6%-6.2%£2.45B£241.46M61.513,000TALKTalkTalk Telecom GroupN/AN/AN/AN/A£1.11B£1.52B7.57500High Trading VolumeAMSAdvanced Medical Solutions Group1.6227 of 5 starsGBX 187.40-1.1%GBX 300+60.1%+2.2%£404.65M£132.18M36.3110Positive NewsDXRXDiaceutics2.3575 of 5 starsGBX 118+4.4%GBX 160+35.6%+13.5%£99.59M£26.08M-35.00151YGENYourgene HealthN/AN/AN/AN/A£16.43M£29.67M-51.50253 Remove Ads Related Companies and Tools Related Companies Scisys Group Alternatives Future Metals Alternatives Burning Rock Biotech Alternatives Connemara Mining Alternatives Amedeo Resources Alternatives Shaftesbury Capital Alternatives TalkTalk Telecom Group Alternatives Advanced Medical Solutions Group Alternatives Diaceutics Alternatives Yourgene Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:AGL) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANGLE plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ANGLE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.